Zinc Lozenges for Shortening Common Cold Duration
Zinc lozenges (zinc acetate or zinc gluconate) at doses ≥75 mg/day, started within 24 hours of symptom onset and continued throughout the cold, significantly reduce common cold duration by approximately 2-3 days. 1
Mechanism of Action
Zinc lozenges work through local release of ionic zinc in the oral cavity and throat, which:
- Binds to ICAM-1 receptors on both rhinovirus particles and nasal epithelial cells, blocking viral attachment and replication 2
- Increases interferon-gamma production 10-fold, enhancing antiviral immune response 3
- Inhibits viral replication through direct antiviral effects on rhinoviruses 3, 2
The key is that only positively charged ionic zinc (not bound zinc) provides therapeutic benefit 3. The lozenge must dissolve slowly in the mouth over 20-30 minutes to maintain adequate zinc ion concentration in the oropharynx where rhinoviruses replicate 3.
Dosing Protocol
Specific dosing requirements:
- Minimum dose: ≥75 mg elemental zinc per day 1
- Timing: Must start within 24 hours of symptom onset 1, 4
- Frequency: One lozenge every 2 hours while awake 5
- Duration: Continue throughout the entire cold 1
- Minimum elemental zinc per lozenge: 13.3 mg 5
Formulation Matters Critically
Zinc acetate and zinc gluconate lozenges are effective; other formulations may not be 1, 6:
- Zinc acetate: Releases 100% ionic zinc 3
- Zinc gluconate: Releases 72% ionic zinc 3
- Both formulations show similar efficacy (zinc acetate 40% reduction vs zinc gluconate 28% reduction in cold duration; difference not statistically significant) 6
Critical formulation pitfall: Lozenges containing citric acid, tartaric acid, sorbitol, or mannitol chelate the zinc ion and eliminate efficacy 3, 5, 7. This explains why approximately half of historical trials showed no benefit—they used formulations that bound the active ionic zinc 3.
Expected Benefits
Duration reduction:
- Average reduction: 2.25-2.37 days 8, 9
- Effect varies by initial cold severity: 8-day reduction for 15-17 day colds, but only 1-day reduction for 2-day colds 10
- Overall 33-40% reduction in cold duration 6
Symptom severity: May provide modest reduction in symptom severity 1
Adverse Effects
Common side effects that must be discussed with patients:
- Bad taste: Most common complaint (RR 2.64) 1
- Nausea: Significant increase (RR 2.15) 1
- Mouth irritation 7
- Overall non-serious adverse events increased (RR 1.34) when used for treatment 8
The likely benefit must be balanced against these side effects, particularly bad taste and nausea 1. Patient tolerance of these effects often limits compliance 5.
Clinical Implementation Algorithm
- Patient presents within 24 hours of cold symptom onset → Zinc lozenges are appropriate
- Patient presents >24 hours after onset → Efficacy uncertain; zinc may still be tried but benefits less established
- Choose formulation: Zinc acetate or zinc gluconate lozenges WITHOUT citric acid, tartaric acid, sorbitol, or mannitol
- Dosing: ≥75 mg/day total, divided as lozenges every 2 hours while awake
- Counsel on side effects: Warn about bad taste and nausea upfront
- Duration: Continue until cold resolves
Important Caveats
Zinc lozenges do NOT prevent colds 8. There is little or no reduction in cold incidence with zinc supplementation (RR 0.93) 8.
Most over-the-counter zinc lozenges are ineffective because they contain chelating agents that bind the ionic zinc 3. Due to inadequate ionic zinc release, very few of the 40+ brands available in the US market are expected to work 3.
Do not confuse with other zinc formulations: The evidence applies specifically to oral lozenges that dissolve slowly in the mouth. Zinc nasal gels have been associated with anosmia (loss of smell) and should be avoided 4. Injectable zinc formulations 11 are for nutritional supplementation in parenteral nutrition, not cold treatment.